Association of the NAD(P)H:Quinone Oxidoreductase (NQO1) 609C→T Polymorphism with Lung Cancer Risk among Male Smokers

This publication has 19 references indexed in Scilit:

• The alpha-tocopherol, beta-carotene lung cancer prevention study: Design, methods, participant characteristics, and compliance
  Published by Elsevier ,2010
• NQO1 T allele associated with decreased risk of later age at diagnosis lung cancer among never smokers: results from a population-based study
  Carcinogenesis: Integrative Cancer Research, 2004
• Oxidative damage-related genes AKR1C3 and OGG1 modulate risks for lung cancer due to exposure to PAH-rich coal combustion emissions
  Carcinogenesis: Integrative Cancer Research, 2004
• Analysis of NQO1, GSTP1, and MnSOD genetic polymorphisms on lung cancer risk in Taiwan
  Lung Cancer, 2003
• NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T polymorphism and the risk of eight cancers for Japanese
  International Journal of Clinical Oncology, 2002
• NAD(P)H: QUINONE OXIDOREDUCTASE POLYMORPHISM AND LUNG CANCER IN TAIWAN
  Journal of Toxicology and Environmental Health, Part A, 1999
• Genotype-phenotype relationships in studies of a polymorphism in NAD(P)H
  Pharmacogenetics, 1999
• Identification of an NAD(P)H:quinone oxidoreductase polymorphism and its association with lung cancer and smoking
  Pharmacogenetics, 1995
• Cytosolic activation of aromatic and heterocyclic amines. Inhibition by dicoumarol and enhancement in viral hepatitis B.
  Environmental Health Perspectives, 1994
• The Effect of Vitamin E and Beta Carotene on the Incidence of Lung Cancer and Other Cancers in Male Smokers
  New England Journal of Medicine, 1994